* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download - Fred Help Centre
Survey
Document related concepts
Pharmaceutical marketing wikipedia , lookup
Compounding wikipedia , lookup
Drug design wikipedia , lookup
Neuropharmacology wikipedia , lookup
Discovery and development of proton pump inhibitors wikipedia , lookup
Pharmacognosy wikipedia , lookup
Electronic prescribing wikipedia , lookup
Pharmacogenomics wikipedia , lookup
Drug discovery wikipedia , lookup
Drug interaction wikipedia , lookup
Pharmaceutical industry wikipedia , lookup
Pharmacokinetics wikipedia , lookup
Prescription drug prices in the United States wikipedia , lookup
Transcript
MARCH 201 2 NEWSLETTER April 2012 Price Reductions The Pharmacy Guild of Australia has created, for members, an in-Store poster and a Stock Management Spreadsheet to assist in the lead-up to the changes of the PBS Listings on 1 April 2012. To access these resources members will need to: • Log in to the Guild website to access the area reserved for members • Click ‘Tools’ to find the documents required. You will all have seen news of GSK’s pre-emptive strike on prices announced to commence 1 March 2012. The GSK items affected are Amoxil; Aropax; Augmentin; Avandamet; Lamictal. We recommend to all Fred Dispense clients the simple expedient of putting stickers onto your Dispensary shelves at the affected items so that re-ordering can be closely monitored and stocks run down before the new wholesale prices come into effect. Fred Office Customers Material designed for Fred Office customers will be available on the Fred Help Centre to assist with these changes, this will show a list of the items which will be affected by 1 April 2012 changes. Labour Day Public Holiday Monday 12 March 2012 is a public holiday in Victoria, Fred Help will still be available between the hours of 8.30am to 9.00pm using the usual phone number 1300 731 888. The Pharmacy Guild ScriptMAP • Do you want the clearest available information on changes to PBS pricing, including the official list of 1 April 2012 price changes, and indicative impact on your pharmacy’s remuneration up to the end of the Fifth Agreement? • Would you like to better understand how to minimise any adverse impact and what can be done to improve the profitability of your pharmacy? • Need to know where your pharmacy can improve generic substitution and dispensing volumes? The ScriptMAP-2015 report uses your own unique dispensing data and the best available information to provide a comprehensive, customised analysis of the impact of the PBS Reforms, patent expiries, and changes to remuneration. It also provides an Action List and guides you through specific changes that may assist your pharmacy, with a focus on generic substitution and dispensing volume growth. ScriptMAP 2015 has recently been enhanced to include the official list of 1 April 2012 price changes. The enhanced version also includes a comprehensive year-by-year analysis of the impact of PBS reforms and patent expires on your pharmacy’s profitability up to the end of the 5th Agreement (201415). Other features of ScriptMAP 2015 include estimates of top line turnover growth and change in percentage gross profit, estimates based on a range of volume growth outcomes (rather than just one level), and a list of drugs where your generic substitution rate is below the national average. The comprehensive, personalised, 34 page ScriptMAP-2015 report is now available at a cost of just $90 plus GST for a single report, or $270 plus GST for a 12 month subscription which includes four reports and a customised ScriptMAP New Brands Report every month. ScriptMAP is only available to Guild members. Guild Members are encouraged to take advantage of the enhanced ScriptMAP 2015 to assist in understanding the full impact of the 1 April 2012 price changes on your pharmacy’s profitability. The Guild ScriptMAP site is available for Guild members at http://www.guild.org.au/scriptmap/ Fred Health Pty Ltd 20 Trenerry Crescent Abbotsford VIC 3067 T 03 9418 1800 Fred Help 1300 731 888 Local Call Cost F 1300 730 888 www.fred.com.au A Fred IT Group Company ScriptMAP Instructions with Fred Dispense Guild ScriptMAP reports are generated from Fred Dispense via ScriptMAP Generation, this is found at the bottom of the Fred Dispense Activities menu <ALT+A>, <UP ARROW>. The ScriptMAP Generation Screen, defaults to the previously completed month and allows the pharmacy to enter their preferred phone and email contact details. Once these details are entered, clicking “Generate and Send” will create the ScriptMAP.txt file which will automatically be transmitted by Fred Connect (provided that the ScriptMAP plugin is installed.) Generally the Pharmacy Guild requires at least 2500 scripts to generate the ScriptMAP report. the following website to order their report. https://www.guild.org.au/scriptmap/index.asp Once the pharmacy has successfully transmitted this they go to Features in Fred Dispense which may be of Assistance With the coming reductions in prices via the PBS it seems a logical time to revisit two ‘Drug Management’ tasks in Fred Dispense which may assist you in controlling your stock, these are: • Manage Stock Groups • Manage Drug Ranking The Drug Management feature has been designed to allow pharmacies to quickly and easily manage drug information within and between pharmacies. It provides bulk creation and management of Stock Groups as well as Drug Ranking. This is designed to assist easier reporting (Stock Groups) as well as quicker dispensing (Drug Ranking). The Drug Management feature is available via the Activities Menu <ALT + A><G> and can be turned on or off via Dispense Options. Manage Stock Groups <ALT + A><G><S> Stock groups are a great way to manage drugs for effective Reporting (for instance by brand or manufacturer). To assist this process, these groups are now able to be viewed and managed in bulk via “Manage Stock Groups”. From “Manage Stock Groups” existing stock groups can be selected via drop down menus where as new stock groups can be added by typing into these fields. The drugs in the group are displayed in the left hand side of the screen www.fred.com.au A Fred IT Group Company The right hand side of screen allows drugs to be added to the group by Manufacturer or by specific selection. Please note: the “Select All” and “Select None” buttons are also available to speed up specific drug selections. Similar to the above addition, drugs can be easily removed from a group using the options on the left hand side of screen. The current Stock Group for the drug displays in the “Current Group” column. A value of “0” indicates that the drug is currently not part of a Stock Group. Please note: drugs can only be part of one Stock Group at a time. www.fred.com.au A Fred IT Group Company Manage Drug Ranking<ALT + A><G><D> By default drugs appear in alphabetical order during dispensing, however Drug Ranking allows this order to be adjusted to suit your needs. More popular drugs can be “ranked” to appear first in the list, enabling fast drug selection during dispensing. Similar to the Manage Stock Groups function, “Manage Drug Ranking” allows the addition of drugs via the right hand side of screen and removal of drugs via the left. The pull down allows you to select the Drug Ranking (1-9) to focus on. Please note: • “1” is the highest possible rank a user may set and “9” is the lowest possible rank. • “5” is considered unranked and is the default rank for all drugs in Fred Dispense. • If you have run the Drug Usage Rank Report, these drugs are given a “0” rank and will always appear highest in the list when dispensing. The current Drug Ranking can be viewed via the “Rank” columns. Drugs can only have one “Rank”. If a drug rank is removed, it will return to the default rank of “5”. Blank Labels and Name and address We have had a number of reports that Medicare is possibly rejecting scripts if the name and address of the Pharmacy does not appear on the coding sticker. After discussions with Medicare we have been assured that, if blank labels are used, adding the Pharmacy stamp (with location details) to the script when submitted will suffice. The legislation, as far as we can interpret, does not seem to refer to the coding stocker, merely to the submitted prescription. www.fred.com.au A Fred IT Group Company MedView launches March 2012 The much anticipated MedView trial will commence rollout in the coming weeks, with the first sites having access to the new infrastructure in March 2012. Participating healthcare professionals and patients in the Barwon Medicare Local region of Victoria will be the first of the national sites to experience the benefits of a combined prescribed and dispensed medications information repository. The benefits of MedView include: • Combined prescribe and dispense information – see other medications prescribed and dispensed by participating Healthcare professionals within the patient’s healthcare team. • Fast, easy processing of scripts – the eRx script exchange platform ensures patient and drug information is transferred quickly and securely into Fred Dispense fields. • Script accuracy – no transcribing errors with information being loaded directly into the local patient fields, with the option to clarify instructions if necessary. • Safer – visibility over a patient’s combined prescribed and dispensed medications history gives you the ability to monitor regime compliance and limit adverse drug interactions. • Discharge information – See hospital discharge medications to ensure continuity of care. • Efficient – giving you the time to focus on the patient’s broader needs. Consolidated information will assist you with making informed suggestions for the sale of complimentary medicines and supporting products. • Cost effective – no charge to install or use MedView. What to do As part of the Commonwealth Government’s eHealth program, all MedView participating healthcare providers across Australia will need to ensure they have the following: • A Health Provider Identifier for Organisations (HPI-O) allocated by the HI Service • A Health Provider Identifier for Individuals (HPI-I) allocated by the HI Service • eRx Script Exchange (essential for the participation in MedView) Healthcare professionals in trial regions will be contacted directly regarding ‘Go Live’ dates in their specific areas. Why do I need to apply for these? You will need a HPI-O (and ultimately a HPI-I) for many of your dealings with Medicare, and the Federal Government under the new Health Identifier (HI) Service. This will also enable you to access MedView, as well as further national infrastructure and eHealth initiatives in the future. You will need to have access to the HI service for Fred Dispense to validate the patient’s IHI (individual Health Identifier). A valid patient IHI is necessary for consenting patient’s information to be uploaded to or viewed in MedView. You need to be registered and using eRx Script Exchange to both contribute to and view medications information through MedView. How do I apply for these? You should apply for your HPI-O via MediCare now so that you are ready for your dealing with the HI Service. For more information on how to apply for your HPI-O and register for eRx and MedView, see the ‘How to Participate’ area of: http://www.medview.com.au/healthcare-professionals or alternatively http://www.medicareaustralia.gov.au/provider/health-identifier www.fred.com.au A Fred IT Group Company HELP CENTRE ? Have you missed a Webinar? We have good news! All recorded Webinars can be viewed (or downloaded) at the following link: https://help.fredhealth.com.au/tags/webinar/Recording/default.aspx Please Note: You will need to be signed into the Fred Help Centre to access these files. Use the link in the very top right hand corner to Sign In or Join the Fred Help Centre to access these. FREE Fred Dispense Training! Perfect for enhancing your skills as well as training new and existing staff or locums, the new Fred Dispense Training CD offers over 3 hours’ worth of training completely FREE! What is included in the Fred Dispense Training CD? • The Dispensing Process • Troubleshooting • Fred Dispense Claiming & Updates • The Fred Dispense Manual • Tips & Tricks How do I access more Online Training? Sign up to the Fred Help Centre for access to over 600 documents and tutorials, hundreds of wiki pages, access to news blogs, wholesaler promotion files, and the popular user forums where you can ask questions to other customers and provide Fred feedback. Click on the following link to find out more: https://help.fredhealth.com.au/blogs/gettingstarted/pages/help.aspx Fax this completed form to 1300 730 888 to order a Fred Dispense Training CD Store Name Store Address State Contact Name Postcode Position Contact email Attention CD delivery to: (if different from above) Name Position Email Please send me (tick all that apply) n Fred Dispense Training CD n Fred Office POS Touchscreen Training CD n Fred Office Ordering & Pricing Upgrade Training CD (2.5 to 3.0) n Fred Office Returns & Credits Training CD n Alternatively, have a Sales Representative contact me to organise face to face training* Further Comments Priceline Pharmacies please note that only the Fred Dispense Training CD applies to you. Please contact Priceline for your Back Office training requirements. * Charges apply for face to face training www.fred.com.au A Fred IT Group Company Remember to scan the eRx barcode eRx Script exchange continues to grow, with more doctors and pharmacies coming online every day. Remember to look for and scan the eRx barcode on the duplicate side of original prescriptions. You will enjoy the benefits of greater efficiencies through high speed receipt of accurate prescription information and improve patient safety through the reduction of transcription errors. If you are not seeing eRx barcodes on doctors’ prescriptions from your local surgeries then we encourage you to have a chat with them about the benefits of eRx – or let us know and we can contact them for you. Should you have any questions or feedback, please don’t hesitate to contact us at [email protected] or on 1300 700 921 Three Xbox’s up for grabs!! Visit Fred on stand 123 & 128 at APP at the Gold Coast Convention and Exhibition Centre, Qld; view a demonstration of the latest Fred Office version and you could win one of three Xbox 360TM consoles. Register Now for the 2012 Season Australia’s only on-line footy tipping competition for the pharmacy industry is back for Season 2012 of AFL and NRL, with $5000 of weekly and end of season prizes up for grabs! Register now for a chance to win a Sherrin AFL or Steeden NRL football. Every week until the AFL season kicks off on 24 March (the NRL begins on 1 March) one PHARMeFOOTY registrant from each code will win a football. Please visit www.pharmefooty.com.au to sign up today. PBS Changes Effective March 2012 We have enclosed in this newsletter a summary of the important changes for your convenience. For the full Schedule of Pharmaceutical Benefits visit http://www.pbs.gov.au/. This page enables you to search by the drug name in the schedule immediately. www.fred.com.au A Fred IT Group Company PHARMACEUTICAL BENEFITS These changes to the Schedule of Pharmaceutical Benefits are effective from 1 March 2012. The Schedule is updated on the first day of each month and is available on the Internet at www.pbs.gov.au. SUMMARY OF CHANGES Additions Addition – Item 3387G Linagliptin, Tablet 5 mg (Trajenta) 2751T 2752W 1081X 8604W 8605X 8606Y 2502Q 2502Q 3058Y 3317N 3119E 3318P 1209P 1210Q 8220P 8703C 8700X 8701Y 8506Q 1434L 2848X 2849Y 2850B 2851C 2456G 2457H 2458J 8331L 8399C 8007K 8007K 8008L 8008L 2893G 5205Y 8470T 1978D 8787L 8869T 8789N 3169T 3170W 9079W 3171X 3172Y 2236Q 8836C 2237R 8837D 2011W 9242K Addition – Brand Auro‐Amlodipine 5, DO – Amlodipine, Tablet 5 mg (as besylate) Auro‐Amlodipine 10, DO – Amlodipine, Tablet 10 mg (as besylate) Atenolol‐PS, FZ – Atenolol, Tablet 50 mg Bisoprolol Pfizer, FZ – Bisoprolol Fumarate, Tablet 2.5 mg Bisoprolol Pfizer, FZ – Bisoprolol Fumarate, Tablet 5 mg Bisoprolol Pfizer, FZ – Bisoprolol Fumarate, Tablet 10 mg Calciprox, GN – Calcitriol, Capsule 0.25 microgram Calcitriol‐PS, FZ – Calcitriol, Capsule 0.25 microgram Cephalexin‐PS, FZ – Cephalexin, Capsule 250 mg Cephalexin‐PS, FZ – Cephalexin, Capsule 250 mg (Dental) Cephalexin‐PS, FZ – Cephalexin, Capsule 500 mg Cephalexin‐PS, FZ – Cephalexin, Capsule 500 mg (Dental) Ciprofloxacin‐PS, FZ – Ciprofloxacin, Tablet 500 mg Ciprofloxacin‐PS, FZ – Ciprofloxacin, Tablet 750 mg Auro‐Citalopram 20, DO – Citalopram Hydrobromide, Tablet 20 mg (base) Auro‐Citalopram 40, DO – Citalopram Hydrobromide, Tablet 40 mg (base) Escitalopram GA, GN – Escitalopram, Tablet 10 mg (as oxalate) Escitalopram GA, GN – Escitalopram, Tablet 20 mg (as oxalate) Exemestane Sandoz, SZ – Exemestane, Tablet 25 mg Fluoxetine‐PS, FZ – Fluoxetine, Capsule 20 mg (as hydrochloride) Lamotrigine‐PS, FZ – Lamotrigine, Tablet 25 mg Lamotrigine‐PS, FZ – Lamotrigine, Tablet 50 mg Lamotrigine‐PS, FZ – Lamotrigine, Tablet 100 mg Lamotrigine‐PS, FZ – Lamotrigine, Tablet 200 mg Lisinopril‐PS, FZ – Lisinopril, Tablet 5 mg Lisinopril‐PS, FZ – Lisinopril, Tablet 10 mg Lisinopril‐PS, FZ – Lisinopril, Tablet 20 mg Omeprazole‐PS, FZ – Omeprazole, Tablet 20 mg Pantoprazole‐PS, FZ – Pantoprazole Sodium Sesquihydrate, Tablet (enteric coated), equivalent to 20 mg pantoprazole Panthron, GN – Pantoprazole Sodium Sesquihydrate, Tablet (enteric coated), equivalent to 40 mg pantoprazole Pantoprazole‐PS, FZ – Pantoprazole Sodium Sesquihydrate, Tablet (enteric coated), equivalent to 40 mg pantoprazole Panthron, GN – Pantoprazole Sodium Sesquihydrate, Tablet (enteric coated), equivalent to 40 mg pantoprazole Pantoprazole‐PS, FZ – Pantoprazole Sodium Sesquihydrate, Tablet (enteric coated), equivalent to 40 mg pantoprazole Prochlorperazine‐PS, FZ – Prochlorperazine, Tablet containing prochlorperazine maleate 5 mg Prochlorperazine‐PS, FZ – Prochlorperazine, Tablet containing prochlorperazine maleate 5 mg (Dental) Ramipril‐PS, FZ – Ramipril, Capsule 10 mg Ranitidine‐PS, FZ – Ranitidine Hydrochloride, Tablet 150 mg (base) Risperidone Pfizer, FZ – Risperidone, Tablet 0.5 mg Risperidone Pfizer, FZ – Risperidone, Tablet 0.5 mg Risperidone Pfizer, FZ – Risperidone, Tablet 1 mg Risperidone Pfizer, FZ – Risperidone, Tablet 1 mg Risperidone Pfizer, FZ – Risperidone, Tablet 2 mg Risperidone Pfizer, FZ – Risperidone, Tablet 2 mg Risperidone Pfizer, FZ – Risperidone, Tablet 3 mg Risperidone Pfizer, FZ – Risperidone, Tablet 4 mg Auro‐Sertraline 50, DO – Sertraline, Tablet 50 mg (as hydrochloride) Auro‐Sertraline 50, DO – Sertraline, Tablet 50 mg (as hydrochloride) Auro‐Sertraline 100, DO – Sertraline, Tablet 100 mg (as hydrochloride) Auro‐Sertraline 100, DO – Sertraline, Tablet 100 mg (as hydrochloride) Auro‐Simvastatin 10, DO – Simvastatin, Tablet 10 mg Auro‐Simvastatin 10, DO – Simvastatin, Tablet 10 mg 2012X 9243L 8173E 9244M 8313M 9245N Auro‐Simvastatin 20, DO – Simvastatin, Tablet 20 mg Auro‐Simvastatin 20, DO – Simvastatin, Tablet 20 mg Auro‐Simvastatin 40, DO – Simvastatin, Tablet 40 mg Auro‐Simvastatin 40, DO – Simvastatin, Tablet 40 mg Auro‐Simvastatin 80, DO – Simvastatin, Tablet 80 mg Auro‐Simvastatin 80, DO – Simvastatin, Tablet 80 mg 8885P Addition – Equivalence Indicator Imigran FDT, GK – Sumatriptan, Tablet (fast disintegrating) 50 mg (as succinate) 8885P Addition ‐Note Denosumab, Injection 60 mg in 1 mL pre‐filled syringe (Prolia) Sumatriptan, Tablet 50 mg (as succinate) (Imigran, Sumatab, Sumagran 50, Pharmacor Sumatriptan 50, APO‐Sumatriptan, Chem mart Sumatriptan, Terry White Chemists Sumatriptan, Sumatriptan‐GA, Sumatriptan generichealth) Sumatriptan, Tablet (fast disintegrating) 50 mg (as succinate) (Imigran FDT) 2502Q 1169M 5045M 1209P 1210Q 1370D 1368B 1369C 2487X 2848X 2849Y 2850B 2851C 2456G 2457H 2458J 2321E 2430X 1801T 2350Q 2349P 2242B 2833D 9237E 2834E 9238F 8197K 9239G 8259Q 9120B 9121C 9122D 8470T 1760P 5260W 8016X 5261X 2236Q 2237R Deletions Deletion – Brand Calcitriol‐DP, GN – Calcitriol, Capsule 0.25 microgram Douglas Cefaclor‐CD, GM – Cefaclor, Tablet 375 mg (sustained release) Douglas Cefaclor‐CD, GM – Cefaclor, Tablet 375 mg (sustained release) (Dental) Ascent Pharmaceuticals Limited, GN – Ciprofloxacin, Tablet 500 mg Ascent Pharmaceuticals Limited, GN – Ciprofloxacin, Tablet 750 mg Enalapril‐DP 5mg, GN – Enalapril, Tablet containing enalapril maleate 5 mg Enalapril‐DP 10mg, GN – Enalapril, Tablet containing enalapril maleate 10 mg Enalapril‐DP 20mg, GN – Enalapril, Tablet containing enalapril maleate 20 mg Pepcidine M, MK – Famotidine, Tablet 20 mg Lamotrigine‐DP, GM – Lamotrigine, Tablet 25 mg Lamotrigine‐DP, GM – Lamotrigine, Tablet 50 mg Lamotrigine‐DP, GM – Lamotrigine, Tablet 100 mg Lamotrigine‐DP, GM – Lamotrigine, Tablet 200 mg Liprace, GM – Lisinopril, Tablet 5 mg Liprace, GM – Lisinopril, Tablet 10 mg Liprace, GM – Lisinopril, Tablet 20 mg Medroxyhexal, HX – Medroxyprogesterone Acetate, Tablet 10 mg Ascent Pharmaceuticals Limited, GN – Metformin Hydrochloride, Tablet 500 mg Ascent Pharmaceuticals Limited, GN – Metformin Hydrochloride, Tablet 850 mg Karicare De‐Lact, SB – Milk Powder—lactose Free Formula, Lactose‐predigested powder infant formula 900 g Karicare De‐Lact, SB – Milk Powder—lactose Free Formula, Lactose‐predigested powder infant formula 900 g Paroxetine‐DP, GM – Paroxetine, Tablet 20 mg (as hydrochloride) Pravastatin 10, MI – Pravastatin, Tablet containing pravastatin sodium 10 mg Pravastatin 10, MI – Pravastatin, Tablet containing pravastatin sodium 10 mg Pravastatin 20, MI – Pravastatin, Tablet containing pravastatin sodium 20 mg Pravastatin 20, MI – Pravastatin, Tablet containing pravastatin sodium 20 mg Pravastatin 40, MI – Pravastatin, Tablet containing pravastatin sodium 40 mg Pravastatin 40, MI – Pravastatin, Tablet containing pravastatin sodium 40 mg Pepti‐Junior Gold, SB – Protein Hydrolysate Formula with Medium Chain Triglycerides, Compound powder 450 g Ramipril‐DP, GN – Ramipril, Capsule 1.25 mg Ramipril‐DP, GN – Ramipril, Capsule 2.5 mg Ramipril‐DP, GN – Ramipril, Capsule 5 mg Ramipril‐DP, GN – Ramipril, Capsule 10 mg Roxide, HX – Roxithromycin, Tablet 150 mg Roxide, HX – Roxithromycin, Tablet 150 mg (Dental) Roxide, HX – Roxithromycin, Tablet 300 mg Roxide, HX – Roxithromycin, Tablet 300 mg (Dental) Concorz, HX – Sertraline, Tablet 50 mg (as hydrochloride) Concorz, HX – Sertraline, Tablet 100 mg (as hydrochloride) 5457F 8144P 2350Q 2349P 8259Q Deletion – Equivalence Indicator Karicare Aptamil De‐Lact, NU – Milk Powder—lactose Free Formula, Lactose‐predigested powder infant formula 900 g Karicare Aptamil De‐Lact, NU – Milk Powder—lactose Free Formula, Lactose‐predigested powder infant formula 900 g Karicare Aptamil Pepti‐Junior Gold, NU – Protein Hydrolysate Formula with Medium Chain Triglycerides, Compound powder 450 g Alterations Alteration – Item Description From: 9329B To: 9329B Essential Amino Acids Formula, Powder 200 g, 2 (Essential Amino Acid Mix) Essential Amino Acids Formula, Powder 200 g (Essential Amino Acid Mix) This alteration of form results in the increase to the maximum quantity for this item from 3 to 6. 5457F 3423E 3424F Alteration – Restriction Denosumab, Injection 60 mg in 1 mL pre‐filled syringe (Prolia) Exenatide, Injection solution 5 micrograms per dose in pre‐filled pen, 60 doses (Byetta 5 microgram) Exenatide, Injection solution 10 micrograms per dose in pre‐filled pen, 60 doses (Byetta 10 microgram) Alteration – Authorised Prescriber The following items can now be prescribed by Nurse Practitioners. 5285E Amlodipine with Valsartan and Hydrochlorothiazide, Tablet 5 mg (as besylate)‐160 mg‐12.5 mg (Exforge HCT 5/160/12.5) 5286F Amlodipine with Valsartan and Hydrochlorothiazide, Tablet 5 mg (as besylate)‐160 mg‐25 mg (Exforge HCT 5/160/25) 5287G Amlodipine with Valsartan and Hydrochlorothiazide, Tablet 10 mg (as besylate)‐160 mg‐12.5 mg (Exforge HCT 10/160/12.5) 5288H Amlodipine with Valsartan and Hydrochlorothiazide, Tablet 10 mg (as besylate)‐160 mg‐25 mg (Exforge HCT 10/160/25) 5289J Amlodipine with Valsartan and Hydrochlorothiazide, Tablet 10 mg (as besylate)‐320 mg‐25 mg (Exforge HCT 10/320/25) Alteration – Manufacturer's Code 8286D Sandrena, AS – Oestradiol, Transdermal gel 1 mg in 1 g sachet, 28 From: MK To: AS REPATRIATION PHARMACEUTICAL BENEFITS 4277D 4050E 4286N 4275B 4252T 4255Y 4258D 4259E 4263J 4266M 4270R 4196W 4207K 4230P 4303L 4306P 3400Y 4307Q 4290T 4302K 4115N 4594T 4595W 4419N 4422R 4462W Additions Addition – Item Alfuzosin Hydrochloride, Tablet 10 mg (Xatral SR) Bandage—compression, Bandage, two layer (Coban) Codeine Phosphate with Aspirin, Tablet 8 mg‐300 mg (Aspalgin 40) Codeine Phosphate with Paracetamol, Tablet 8 mg‐500 mg (Panamax Co. 40) Dressing—foam—silver, Dressings, adhesive, 7.5 cm x 7.5 cm, 10 (Allevyn Ag Adhesive 66800073) Dressing—foam—silver, Dressings, adhesive, 10 cm x 10 cm, 10 (Allevyn Ag Adhesive 66800075) Dressing—foam—silver, Dressings, adhesive, 12.5 cm x 12.5 cm, 10 (Allevyn Ag Adhesive 66800078) Dressing—foam—silver, Dressings, non‐adhesive, 10 cm x 10 cm, 10 (Allevyn Ag Non‐Adhesive 66800086) Dressing—foam—silver, Dressings 7.5 cm x 7.5 cm, 10 (Allevyn Ag Gentle 66800460) Dressing—foam—silver, Dressings 10 cm x 10 cm, 10 (Allevyn Ag Gentle 66800461) Dressing—foam—silver, Dressings 12.5 cm x 12.5 cm, 10 (Allevyn Ag Gentle 66800462) Dressing—foam with Silicone—heavy Exudate, Dressings 10 cm x 10 cm, 10 (Allevyn Gentle 66800248) Dressing—foam with Silicone—heavy Exudate, Dressings 7.5 cm x 7.5 cm, 10 (Allevyn Gentle Border 66800269) Dressing—foam with Silicone—heavy Exudate, Dressings 10 cm x 10 cm, 10 (Allevyn Gentle Border 66800270) Finasteride, Tablet 5 mg (Finpro) Lubricating Gel, Tube 100 g (Lubri‐Gel) Miconazole Nitrate, Cream 40 g (2% miconazole) (Resolve Thrush) Sunscreens, Cream 75 g (Sunsense Sensitive SPF 30+) Vardenafil, Tablet 10 mg (Levitra) Vardenafil, Tablet 20 mg (Levitra) Addition – Brand Zedd 500, QA – Azithromycin, Tablet 500 mg (as dihydrate) Gabatine 600, QA – Gabapentin, Tablet 600 mg Gabatine 800, QA – Gabapentin, Tablet 800 mg Fibre Health Orange Smooth Sugar Free, PP – Psyllium Hydrophilic Mucilloid, Oral powder (orange‐flavoured, sugar‐free) 283 g Fibre Health Natural Granular, PP – Psyllium Hydrophilic Mucilloid, Oral powder (non‐flavoured) 336 g Micolette, AE – Sorbitol with Sodium Citrate and Sodium Lauryl Sulfoacetate, Enemas 3.125 g‐450 mg‐45 mg in 5 mL, 4 Alterations Alteration – Item Description From: 4935R To: 4935R Dressing with Cadexomer Iodine, Sachets 5 g (6 cm x 4 cm), 5 (Iodosorb 66051330) Dressing with Cadexomer Iodine, Sheets 5 g (6 cm x 4 cm), 5 (Iodosorb 66051330) From: 4937W To: 4937W From: 4481W To: 4481W Dressing with Cadexomer Iodine, Sachets 17 g (10 cm x 8 cm), 2 (Iodosorb 66051360) Dressing with Cadexomer Iodine, Sheets 17 g (10 cm x 8 cm), 2 (Iodosorb 66051360) Tolnaftate, Spray aerosol, 100 g (Tinaderm) Tolnaftate, Spray aerosol 0.7 mg per g (0.07%), 100 g (Tinaderm) Advance Notices Advance Notices – Deletion of Item The following items will be deleted from the Schedule of Pharmaceutical Benefits on 1 April 2012: Item discontinued by the manufacturer— 8443J 3066J Amino Acids—synthetic, Formula, Compound powder 400 g (Neocate) Amino Acids—synthetic, Formula, Compound powder 400 g (Neocate) The following items will be deleted from the Schedule of Pharmaceutical Benefits on 1 May 2012: Item discontinued by the manufacturer— 5398D 5397C 1658G Naproxen, Oral suspension 125 mg per 5 mL, 474 mL (Naprosyn)(Palliative Care) Naproxen, Oral suspension 125 mg per 5 mL, 474 mL (Naprosyn)(Palliative Care) Naproxen, Oral suspension 125 mg per 5 mL, 474 mL (Naprosyn) Advance Notices – Deletion of Brand The following brands will be deleted from the Schedule of Pharmaceutical Benefits on 1 April 2012: Brand discontinued by the manufacturer— 1434L 8313M 9245N Fluohexal, HX – Fluoxetine, Capsule 20 mg (as hydrochloride) Simvahexal, HX – Simvastatin, Tablet 80 mg Simvahexal, HX – Simvastatin, Tablet 80 mg EFFICIENT FUNDING OF CHEMOTHERAPY – SECTION 100 ARRANGEMENTS SUMMARY OF CHANGES The explanatory notes section of this schedule provides information on the prescribing and dispensing of chemotherapy drugs under the Efficient Funding of Chemotherapy Drugs — Section 100 Arrangements. In addition to the commencement of these new arrangements, the changes listed below take effect from 1 March 2012. Additions Addition – Form Solution concentrate for I.V. infusion 200 mg (as hydrochloride) in 5 mL (Gemcitabine Ebewe, SZ) Solution concentrate for I.V. infusion 1 g (as hydrochloride) in 25 mL (Gemcitabine Ebewe, SZ) Solution concentrate for I.V. infusion 2 g (as hydrochloride) in 50 mL (Gemcitabine Ebewe, SZ) 7246J, 4439P 7246J, 4439P 7246J, 4439P Gemcitabine Injection Gemcitabine Injection Gemcitabine Injection 7231N, 4375G 7231N, 4375G 7231N, 4375G 7231N, 4375G 7231N, 4375G Epirubicin Injection/ intravesical Addition – Brand Epirubicin Actavis 10, TA (Solution for injection 10 mg in 5 mL) Epirubicin Injection/ intravesical Epirubicin Actavis 20, TA (Solution for injection 20 mg in 10 mL) Epirubicin Injection/intravesical Epirubicin Actavis 50, TA (Solution for injection 50 mg in 25 mL) Epirubicin Injection/ intravesical Epirubicin Actavis 100, TA (Solution for injection 100 mg in 50 mL) Epirubicin Injection/ intravesical Epirubicin Actavis 200, TA (Solution for injection 200 mg in 100 mL) Alterations Alteration – Restriction All forms of Gemcitabine are now unrestricted. Alteration – Note 7246J, 4439P Gemcitabine Injection MONTHLY UPDATE PROCEDURE FOR Please tick 3 and initial when step is completed > STEP 1 PERFORMING A BACKUP A backup must be performed before running the Fred Dispense Monthly update. The pre-update backup takes a copy of the Fred Dispense data and programs before you upgrade to a later version. It is recommended that this backup is taken away from the pharmacy and stored off-site. It is recommended that you perform the backup after receiving the update notification email or before running Step 3 for the program update. Please tick 3 and initial when step is completed > STEP 2 DOWNLOAD UPDATE USING FRED CONNECT Within 24 hours of receiving the Monthly Update Email Fred Connect automatically downloads the Fred Dispense Update. Alternatively you can use Fred Connect to download the update manually 1. Right click on the Fred Connect icon found in the system tray and left click on Show 3. Left click on the Select Program Updates to Download button. A window will appear showing the list of updates available. Scroll to the bottom of the list and tick the box next to the update required. Left click the Download Selected Updates button to begin downloading the update. 2. Left click on the Plugins Tab then left click on the Utility Configuration Tab 4. The Fred Connect program will switch to the Downloads tab where the update download progress is shown. At this time you may wish to wait until the download completes. Alternatively Fred Connect can be sent back to the system tray by left clicking on the cross on the top right hand side of the window. The update will continue to download and dispensing can continue. Please tick 3 and initial when step is completed > STEP 3 RUNNING THE PROGRAM UPDATE The next time the Fred Dispense program is re-opened after the update has downloaded; a prompt will appear to run the program update. At this point Fred Dispense and Fred Connect should be exited on all computers. 1. Close Fred Dispense on all computers using <ALT + X> 2. Close Fred Connect by right clicking the Fred Connect icon in the system tray and choosing STOP. You can then choose YES to the prompt to run the program update. You DO NOT need to wait until the end of the month to run the Program Update step. Please tick 3 and initial when step is completed > STEP 4 RUNNING THE DRUG UPDATE This step is to be run after close of trade on the last trading day of the month. 1. Exit Fred Dispense and Fred Connect on all computers 2. Left click on the Windows Start Menu and choose Programs, Fred, Fred Dispense, Drug Update. 3. After performing the drug update Fred Dispense will run with new Drug details and prices. This can be checked by pressing <F7> Quick Drug Price lookup from Fred Dispense and typing TEST <ENTER> to check if the current month’s Test Drug is displayed at the top of the screen. If you are not receiving the monthly update notification email, make sure Fred Health has your current email address. To advise us of any change to your email address please call Fred Help on 1300 731 888 or email [email protected] 25% OFF AusDI Online and AusDI Mobile for iPhone and iPad! *Normal subscription $295 excl. GST, offer expires 30th April 2012. This offer is open to new customers only. Evidence-based, independent, and comprehensive drug information The comprehensive drug reference 2770 Product Information Sheets 2880 Consumer Medicines Information Leaflets 1100 Drug Product Monographs 2440 Drug Product Images Features Search for: Full drug product information (PIs) Drug product images searchable by colour, markings and shape Consumer medicines information (CMIs) Full text, evidence-based drug, drug-class and complementary drug product monographs Patient counselling points Patient monitoring recommendations Indications Precautions in geriatric patients and other patient population groups Contraindications Side effects and symptoms Dosage recommendations Products not marketed in Australia Pharmacy Board Listed Reference A listed reference by the Pharmacy Board of Australia for: Prescription products Drug Interactions Evidence-based reference work on complementary and alternative medicines Now integrated with Available in the following formats Our Partners BY INTERNET: www.phoenixmedical.com.au/subscribe PROMOTIONAL CODE: FRED0212 BY PHONE: Contact our AusDI Advanced Sales team on 1300 118 120 and quote “FRED0212” BY FAX: Simply complete the form on the back and fax to 02 9947 2547 AusDI Advanced Order Form FAX BACK (02) 9947 2547 AusDI Advanced 1 Year online subscription* Price GST $221.25 $22.13 * Single user licence - 25% off standard subscription of $295 excl. GST for new customers only. Offer expires 30th April 2012. First Name Quantity $ TOTAL Surname Organisation Address Postcode ) Tel ) Fax E-mail Payment methods: POST CHEQUE: Payable to Health Communication Network Ltd OR FAX: Credit Card details on this form to: (02) 9947 2547 OR BY PHONE: 1300 118 120 Mon-Fri 9am – 5pm EST Credit card details: Visa To: PO Box 67 St Leonards NSW 1590 Mastercard Number Expiry _____/_____ Amount $ Cardholder Name *25% Discount offer for new customers only. Offer expires 30th April 2012. Date: Signature Amount $